MISS TANYA ROBERT D ONGBIN MD
Prescription History 1831970839
Internal Medicine - Infectious Disease in Little Rock, AR
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MISS TANYA ROBERT D ONGBIN MD, an active Infectious Disease specialist practicing in Little Rock, AR. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 73 documented patient claims. Among these therapy options, the most frequently utilized medication is Ceftriaxone, which accounts for 15 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other AR PrescribersVs. AR Avg |
|---|---|---|---|
| CeftriaxoneCeftriaxone Sodium | 15 | $591.78 | ▼ Less than typical |
About Ceftriaxone: Ceftriaxone is used to treat a wide variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details. A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. In 2024, this provider wrote 15 Medicare prescriptions for Ceftriaxone, about half the volume of the typical Arkansas prescriber of this medication (32.6). Medicare paid an average of $591.78 per fill, versus $52.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 107 Days of Medication total across all patients in 2024 | |||
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $3,946.75▼ below AR avg | ▼ Less than typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 12 Medicare prescriptions for Biktarvy, about a quarter of the volume of the typical Arkansas prescriber of this medication (54.7). Medicare paid an average of $3,946.75 per fill, versus $3,999.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AR average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Ciprofloxacin Hcl | 12 | $11.36 | ▼ Less than typical |
About Ciprofloxacin Hcl: This medication is used to treat a variety of bacterial infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A broad-spectrum antimicrobial carboxyfluoroquinoline. In 2024, this provider wrote 12 Medicare prescriptions for Ciprofloxacin Hcl, about half the volume of the typical Arkansas prescriber of this medication (28.0). Medicare paid an average of $11.36 per fill, versus $6.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| TriumeqAbacavir/Dolutegravir/Lamivudi | 12 | $3,687.27▼ below AR avg | ▼ Less than typical |
About Triumeq: This product contains 3 drugs: abacavir, dolutegravir, and lamivudine. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir and lamivudine belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Dolutegravir belongs to a class of drugs known as integrase inhibitors. This medication is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A combination of abacavir/dolutegravir/lamivudine. In 2024, this provider wrote 12 Medicare prescriptions for Triumeq, about a third of the volume of the typical Arkansas prescriber of this medication (33.7). Medicare paid an average of $3,687.27 per fill, versus $3,713.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AR average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Doxycycline Monohydrate | 11 | $44.77 | ▼ Less than typical |
About Doxycycline Monohydrate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 11 Medicare prescriptions for Doxycycline Monohydrate, about a third of the volume of the typical Arkansas prescriber of this medication (28.4). Medicare paid an average of $44.77 per fill, versus $13.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 283 Days of Medication total across all patients in 2024 | |||
| Vancomycin Hcl | 11 | $334.62 | ▼ Less than typical |
About Vancomycin Hcl: Vancomycin is used to treat a certain intestinal condition (colitis) that may rarely happen after treatment with antibiotics. Show more ▾ This condition causes diarrhea and stomach/abdominal discomfort or pain. When vancomycin is taken by mouth, it stays in the intestines to stop the growth of bacteria that cause these symptoms. This antibiotic treats only bacterial infection in the intestines. It will not work for bacterial infections in any other part of the body or for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. In 2024, this provider wrote 11 Medicare prescriptions for Vancomycin Hcl, about a third of the volume of the typical Arkansas prescriber of this medication (34.5). Medicare paid an average of $334.62 per fill, versus $181.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 86 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MISS TANYA ROBERT D ONGBIN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Little Rock, AR practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among AR prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
